Pseudotime analysis showed that HSPA1B+ Tcm was positioned at a late stage of development, suggesting that as HCC develops, this subpopulation of cells is stimulated by antigens, proliferates, and differentiates to exert antitumor effects (Figure 6I). Here, HSPA1B is linked to hepatocellular carcinoma.